Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Rapid rituximab infusion is safe and well tolerated in malignant and benign disease.

Autor: Ursu SG; Division of Hematology and Cellular Therapy, 6596Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA., Rinchuse DL; Division of Hematology and Cellular Therapy, 6596Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA., Lister J; Division of Hematology and Cellular Therapy, 6596Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA.

Publikováno v: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2021 Dec; Vol. 27 (8), pp. 1919-1922. Date of Electronic Publication: 2020 Dec 07.